Abstract

The aim of this thesis is to study the clinical, economic and quality-of-life considerations for clinical decision-making and policy development in cardiovascular interventions. More specifi cally the goals are: 1. To investigate the disease prevalence, adoption trends, quality of life, and economic aspects associated with therapies of aortic stenosis. 2. To explore the economic and policy aspects of alternative revascularization therapies for coronary artery disease. 3. To study the performance of risk prediction models in cardiovascular clinical decisionmaking. 4. To appraise and improve the methodology of cardiovascular research, including systematic reviews, cost-eff ectiveness analyses, and observational studies.

, , ,
A.P. Kappetein (Arie Pieter)
Erasmus University Rotterdam
The research in this thesis was partially fi nancially supported by a Fulbright Scholarship, awarded by the J. William Fulbright Foreign Scholarship Board and The Bureau of Educational and Cultural Aff airs of the United States Department of State. Financial support by the Dutch Heart Foundation and H. Huysmans Foundation for the publication of this thesis is gratefully acknowledged.
hdl.handle.net/1765/77549
Erasmus MC: University Medical Center Rotterdam

Osnabrugge, R. (2015, February 25). Costs, Quality and Value in Cardiovascular Interventions. Retrieved from http://hdl.handle.net/1765/77549